Twist Bioscience (TWST) Change in Accured Expenses (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Change in Accured Expenses data on file, last reported at $35.2 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $35.2 million, up 537.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.1 million (up 15699.59% YoY), and the FY2025 annual result was $6.6 million, down 16.04% from the prior year.
• Change in Accured Expenses climbed to $35.2 million in Q1 2026 per TWST's latest filing, from -$12.4 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $35.2 million in Q1 2026 and troughed at -$12.4 million in Q4 2025.
• A 5-year average of $2.7 million and a median of -$456000.0 in 2023 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses soared 2232.46% in 2024, then sank 1969.22% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at -$3.7 million in 2022, then plunged by 36.65% to -$5.1 million in 2023, then jumped by 88.16% to -$601000.0 in 2024, then slumped by 1969.22% to -$12.4 million in 2025, then soared by 383.28% to $35.2 million in 2026.
• Business Quant data shows TWST's Change in Accured Expenses at $35.2 million in Q1 2026, -$12.4 million in Q4 2025, and $11.3 million in Q3 2025.